SaliPen
Commercial- Indications
- Xerostomia (dry mouth)
Company intelligence / Profile preview
Saliwell
Israelsaliwell.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Saliwell has developed and commercialized the SaliPen®, an FDA-cleared, non-invasive intraoral electrostimulation device that provides relief from dry mouth by stimulating natural saliva production. The company’s technology offers a side effect–free alternative to pharmacological treatments and is positioned as the only non-medication cure available for dry mouth[1][2][4].
- Therapeutic areas
- Other
- Modalities
- DeviceNon-pharmacological therapy
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Saliwell.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Saliwell.